Correction: Cost-effectiveness analysis of sintilimab plus pemetrexed and platinum versus chemotherapy alone as first-line treatment in metastatic non-squamous non–small cell lung cancer in China
Crossref DOI link: https://doi.org/10.1186/s13561-023-00419-w
Published Online: 2023-01-18
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Huiqin
Wang, Ying
He, Qi
Text and Data Mining valid from 2023-01-18
Version of Record valid from 2023-01-18
Article History
First Online: 18 January 2023